4//SEC Filing
Shenouda Maged 4
Accession 0001213900-22-081519
CIK 0001553643other
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 7:31 PM ET
Size
5.9 KB
Accession
0001213900-22-081519
Insider Transaction Report
Form 4
Shenouda Maged
Chief Financial Officer
Transactions
- Other
Stock Option (right to buy)
2022-12-16−200,000→ 0 totalExercise: $19.03Exp: 2031-12-17→ Common stock (200,000 underlying)
Footnotes (3)
- [F1]Represents the termination of milestone-based stock options granted to the reporting person on May 25, 2022, that were eligible to vest based on achievement of certain corporate objectives by the Issuer. Upon grant, the target vesting amount was reported in Table II of Form 4. On December 16, 2022, the Board of Directors determined that such milestone objectives were not achieved by the Issuer and that all 200,000 options would be terminated.
- [F2]Not applicable.
- [F3]Original expiration date.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001658369
Filing Metadata
- Form type
- 4
- Filed
- Dec 19, 7:00 PM ET
- Accepted
- Dec 20, 7:31 PM ET
- Size
- 5.9 KB